Patent Assignment
Reel/Frame 065745/0740
Change of Name
Recorded: 2023-12-01
Pages: 8
Assignor
MAXIVAX SA
Executed: 2023-09-27
Assignee
RELEASE THERAPEUTICS SA
AVENUE DE SÉCHERON 15, GENEVE, 1202, SWITZERLAND
Covered Properties
(5)
Immortalized Myoblast Cell Lines and Uses Thereof
Application:
17/634,563 →
Publication:
US 2022/0265727
Implantable Capsule
Application:
17/635,011 →
Publication:
US 2022/0287959
Vaccination with Immuno-Isolated Cells Producing an Immunomodulator
Vaccination with Immuno-Isolated Cells Producing an Immunomodulator
Vaccination with Immuno-Isolated Cells Producing an Immunomodulator
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 10, 2014
From: MACH, NICOLAS
To: NOVIMMUNE S.A.
Reel/Frame 033707/0724 →
Assignment of Assignor's Interest
Sep 16, 2014
From: NOVIMMUNE SA
To: MAXIVAX SA
Reel/Frame 033744/0400 →
Assignment of Assignor's Interest
Nov 7, 2016
From: MACH, NICOLAS
To: MAXIVAX SA
Reel/Frame 040244/0483 →
Assignment of Assignor's Interest
Feb 11, 2022
From: LATHUILIÈRE, AURÉLIEN; MACH, NICOLAS; SALMON, PATRICK
To: MAXIVAX SA; LES HOPITAUX UNIVERSITAIRES DE GENEVE; UNIVERSITE DE GENEVE
Reel/Frame 058989/0063 →
Assignment of Assignor's Interest
Feb 14, 2022
From: LATHUILIÈRE, AURÉLIEN; GROGG, JULIEN; MACH, NICOLAS
To: MAXIVAX SA; LES HOPITAUX UNIVERSITAIRES DE GENEVE; UNIVERSITE DE GENEVE
Reel/Frame 058999/0585 →